Skip to main content
Daily Report

Daily Sepsis Research Analysis

01/20/2026
3 papers selected
34 analyzed

Analyzed 34 papers and selected 3 impactful papers.

Summary

Three high-impact studies advanced sepsis science across mechanisms, outcomes, and early hemodynamic stratification. A mechanistic study identified an oxylipin-dependent quorum sensing pathway in burn-associated Pseudomonas aeruginosa driving dissemination and mortality, with an enzyme inhibitor (AB012) and OdsA immunization improving survival in mice. A systematic review/meta-analysis quantified 11% long-term mortality after pediatric sepsis, and a machine-learning study validated vital sign–lactate clusters that predict vasopressor use and 28-day mortality across two large cohorts.

Research Themes

  • Pathogen virulence mechanisms and anti-virulence therapeutics in burn sepsis
  • Long-term outcomes and post-discharge risk after pediatric sepsis
  • AI-driven early hemodynamic stratification for vasopressor decision-making

Selected Articles

1. The Oxylipin Dependent Quorum Sensing System enhances Pseudomonas aeruginosa dissemination during burn-associated infection.

81.5Level VBasic/Mechanistic study
PLoS pathogens · 2026PMID: 41557731

In burn models, host-derived oleic acid is converted by P. aeruginosa into oxylipin autoinducers that activate an ODS regulon, driving tissue invasion and systemic dissemination. ODS-deficient mutants were attenuated, and both OdsA immunization and a small-molecule OdsA inhibitor (AB012) reduced dissemination and improved survival without impairing bacterial growth.

Impact: This study reveals a host–pathogen lipid signaling axis driving hypervirulence and provides a druggable enzyme (OdsA) with both vaccine and small-molecule avenues, positioning anti-virulence strategies to prevent sepsis in burn patients.

Clinical Implications: Anti-virulence interventions targeting OdsA—either as adjunct prophylaxis (vaccination) or early post-burn therapy (small-molecule inhibitors)—could reduce dissemination and sepsis risk in burn patients without exerting bactericidal pressure that drives resistance.

Key Findings

  • Thermal injury increased free oleic acid in skin, which P. aeruginosa converted to oxylipins (10-HOME, 7,10-DiHOME) via OdsA/OdsB.
  • ODS activation promoted burn wound invasion, endothelial translocation, and systemic dissemination; ODS mutants showed attenuated colonization and mortality.
  • OdsA immunization and a small-molecule inhibitor (AB012) reduced oxylipin synthesis, ODS gene expression, biofilm formation, dissemination, and improved survival without inhibiting growth.

Methodological Strengths

  • Multi-pronged mechanistic approach combining murine burn model, genetic mutants, immunization, and small-molecule inhibition.
  • Target validation with in vivo efficacy and high-throughput screening identifying a competitive OdsA inhibitor.

Limitations

  • Preclinical study in murine models; human safety, pharmacokinetics, and efficacy remain to be established.
  • Pathogen- and context-specific (burn wound); generalizability to other hosts or pathogens is untested.

Future Directions: Translate OdsA-targeted strategies to large-animal models and early phase clinical trials; define pharmacology, resistance potential, and synergy with standard burn care and antibiotics.

Pseudomonas aeruginosa is a leading cause of life-threatening infections in burn patients, yet the molecular cues driving its hypervirulence remain poorly understood. Here, we identify the Oxylipin Dependent Quorum Sensing (ODS) system as a key regulator of P. aeruginosa pathogenicity in the burn wound environment. Using a murine burn model, we show that thermal injury significantly increases free oleic acid levels in skin, which P. aeruginosa converts into oxylipin autoinducers (10-HOME and 7,10-DiHOME) via OdsA and OdsB. These molecules activate the ODS regulon, promot

2. Long-term mortality in pediatric sepsis: a systematic review and meta-analysis.

75.5Level IISystematic Review/Meta-analysis
Annals of medicine · 2026PMID: 41555746

This PROSPERO-registered PRISMA-compliant meta-analysis pooled six studies (11,318 patients) and estimated 11% long-term mortality after pediatric sepsis, highlighting sustained post-discharge vulnerability. Results were consistent across varying follow-up windows and settings but showed substantial heterogeneity.

Impact: Quantifying long-term mortality reframes sepsis as a chronic condition in survivors and provides evidence to justify structured post-discharge surveillance and targeted follow-up programs.

Clinical Implications: Implement standardized post-discharge follow-up for pediatric sepsis survivors, including risk stratification, early rehabilitation, immunization review, and monitoring for recurrent infection and organ dysfunction.

Key Findings

  • Pooled long-term mortality after pediatric sepsis was 11% (95% CI: 7–16%) across six studies and 11,318 patients.
  • The review was PRISMA-compliant and PROSPERO-registered, using random-effects modeling; substantial heterogeneity was noted.
  • Findings emphasize persistent vulnerability of pediatric sepsis survivors beyond hospital discharge.

Methodological Strengths

  • Registered protocol (PROSPERO) and PRISMA adherence ensure transparency and rigor.
  • Random-effects meta-analysis across diverse settings strengthens generalizability.

Limitations

  • Only six studies met inclusion criteria, and heterogeneity was substantial.
  • Potential confounding and variable sepsis definitions and follow-up durations across included studies.

Future Directions: Conduct high-quality longitudinal cohorts to identify modifiable risk factors, standardize outcome definitions, and test structured post-discharge care pathways for impact on survival.

BACKGROUND: Pediatric sepsis represents a significant factor in the mortality rates among children, with survivors remaining highly fragile during the period following discharge. While in-hospital and short-term mortality have been widely studied, the long-term mortality of pediatric sepsis is not adequately synthesized or appreciated. This study aims to estimate the long-term mortality associated with pediatric sepsis, providing a basis for optimizing post-discharge surveillance and care protocols. METHODS: This systematic review and meta-analysis followed PRISMA guidelines an

3. Machine Learning-Based Clusters of Vital Signs and Lactate Levels Predict Vasopressor Use in Sepsis.

68.5Level IIICohort
Clinical and experimental emergency medicine · 2026PMID: 41554280

Across 17,500 patients from ED septic shock (KOSS) and ICU suspected infection (MIMIC-IV), k-means clustering of initial vital signs and lactate identified a high-risk cluster with lowest MAP and highest diastolic shock index that had the highest vasopressor use, second vasopressor need, and 28-day mortality in both cohorts.

Impact: Validating simple, data-driven clusters across independent datasets supports pragmatic early stratification for vasopressor decisions and trial enrichment strategies in sepsis.

Clinical Implications: Use initial vital signs and lactate-derived clusters to trigger earlier hemodynamic escalation (vasopressors) and allocate resources; prospective validation could enable protocolized, phenotype-guided care.

Key Findings

  • k-means clustering of six vital signs and lactate produced three clusters in both KOSS (n=7,130) and MIMIC-IV (n=10,370).
  • The cluster with lowest MAP and highest diastolic shock index had the highest vasopressor use (KOSS 93.9%; MIMIC-IV 41.0%), second vasopressor need (KOSS 33.5%; MIMIC-IV 16.7%), and 28-day mortality (KOSS 25.3%; MIMIC-IV 29.0%).
  • Physiologic and outcome patterns were concordant across ED and ICU settings, supporting external validity.

Methodological Strengths

  • Large, multicohort analysis with replication across ED and ICU datasets (KOSS, MIMIC-IV).
  • Simple, interpretable features (vital signs and lactate) enabling pragmatic clinical implementation.

Limitations

  • Retrospective design with potential confounding and lack of causal inference.
  • Unsupervised cluster selection and absence of prospective, protocolized validation for guiding therapy.

Future Directions: Prospective, randomized evaluations of cluster-guided hemodynamic protocols, integration with additional biomarkers, and assessment of impact on time-to-vasopressor and mortality.

OBJECTIVE: Sepsis remains a major clinical challenge because of its complex, heterogeneous, and multidimensional clustering patterns. This study aimed to investigate the association between vasopressor administration and machine learning-derived clusters based on initial vital signs and lactate measurements obtained in emergency department (ED) and intensive care unit (ICU) settings. METHODS: A retrospective cohort analysis was performed using data from the Korean Shock Society Septic Shock (KOSS) Registry (septic shock in the ED) and the Marketplace for Medical Information in Intensiv